You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Optimization of Iron Chelator Delivery System

    SBC: GWATHMEY, INC.            Topic: N/A

    Location GWATHMEY, INC. 763 E CONCORD AVE CAMBRIDGE, MA 02138 United States 2R44HL068354-02A2 $3 900 210.00 2 008 Optimization of Iron Chelator Delivery System Department of Health and Human Services National Institutes of Health SBIR Y N Y PHS2007-2 GWAT ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  2. Novel Catheter for Treatment of Ventricular Tachycardia

    SBC: Thermedical Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Ischemic ventricular tachycardia (VT) is a contributing cause to more than half of the 300,000 sudden cardiac deaths that occur annually in the United States. Implantable cardioverter defibrillators (ICDs) are the stand ard therapy but they are expensive the total cost of an ICD implant approaches 50,000 and the United States spends more than 2.2B on these im ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  3. Development and Performance Evaluation of a Handheld Noninvasive Glucose Monitor

    SBC: VIVASCAN CORPORATION            Topic: N/A

    Location 100 Grove Street Suite 315 Worcester, MA 01605 United States 2R44DK059088-04 $2 892 330.00 2 008 Development and Performance Evaluation of a Handheld Noninvasive Glucose Monitor Department of Health and Human Services National Institutes of Healt ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  4. Neuroprotective Apolipoprotein-E Analogs Continuation

    SBC: COGNOSCI INC            Topic: N/A

    DESCRIPTION (provided by applicant): Traumatic brain injury (TBI), principally as a result of impaction on the intact closed skull, occurs in vehicular incidents, falls, acts of violence, and sports accidents. TBI is the leading cause of death and disability in the United States, with an annual incidence rate of 1.5 million. Of these, 50,000 die acutely, over 230,000 are hospitalized, and 80,000 ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  5. SmartInsulin Stability, Process Development, Assay Validation and GMP Manufacturi

    SBC: SMARTCELLS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The Company is developing SmartInsulin(tm), which is intended to be a once-a-day, self- regulating insulin injection for the treatment of Type I diabetes. It is designed as a "drop- in" replacement product for the 4 million insulin-using diabetics in the United States. SmartInsulin is designed to provide significant benefits to insulin-dependent diabetics inclu ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  6. Continuing the Research and Development of Parent Treatment for Child Social

    SBC: 3-C Institute for Social Development, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Problematic peer relations, particularly when chronic, can have a tremendous impact on children's functioning and mental health. Decades of research indicate that peer rejection, isolation, and victimization negatively impact adjustment and place children at increased risk for a myriad of later negative outcomes. Prevention and treatment research supports the ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  7. Click Chemistry for Immobilized Bone Morphogenetic Protein

    SBC: AFFINERGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Growth factors are potent signaling molecules, initiating essential cellular programs for differentiation, proliferation and survival. Only recently have large molecules like growth factors, been employed to enhance the efficacy and specificity of medical implant therapies. In particular, procedures that require native tissues to interact with an implanted mat ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  8. A Potent Oral Therapy for Cytomegalovirus Infection

    SBC: MICROBIOTIX, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Human cytomegalovirus (HCMV) infections continue to represent a major health concern in the immunocompromised population, especially recipients of bone marrow and solid-organ transplants. HCMV remains an important cause of congenital viral infection associated with deafness, mental retardation and mortality. Current therapy, which includes ganciclovir (GCV), c ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  9. System for Automatic Segmentation of Male Pelvis Structures from CT Images

    SBC: MORPHORMICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Image segmentation is a commonly performed clinical practice for extracting geometrical descriptions of internal anatomical objects from volume images such as computed tomography and magnetic resonance images. Shortcomings of current practice have motivated an important area of research involving statistically trainable deformable-shape models (DSMs) for automa ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  10. Herpes virus typing assay for detecting genital herpes

    SBC: BIOHELIX CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of our NIAID Biodefense Phase I SBIR program was to develop, and commercialize field deployable nucleic acid analysis devices for use in biodefense applications. We have begun to sell IsoAmp II kits that will allow our clients to develop home brew assays (we list customers in the commercialization plan). For example, the LANL has obtained NIH fu ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government